This is the authors' abstract. We don't add key points for this paper.
The mitochondrial bioenergetics hypothesis suggests a critical role for mitochondrial function in aging, with its deterioration contributing to multiple age-related diseases. A superior approach to counteract age-dependent declines in cellular NAD + levels is to activate nicotinamide phosphoribosyltransferase (NAMPT), a rate-limiting enzyme in the NAD + salvage pathway that produces the NAD + precursor nicotinamide mononucleotide. NAMPT inhibitors are also desirable for their potency in limiting cancer cell growth. Here, we present an in silico screening of NAMPT modulators using compounds from traditional African, Chinese, and Russian medicinal plants. Compounds were selected based on predicted blood-brain barrier permeability, low toxicity, favorable pharmacokinetic and drug-likeness characteristics, and molecular docking scores against the crystal structures of NAMPT. A panel of 21 compounds, comprising known NAMPT activators, inhibitors, negative controls, and randomly selected compounds, was used to validate the docking method. 2D protein-ligand interactions of the selected compounds were critically evaluated and compared with those of the control panel. The virtual screening yielded 17 compounds with lower predicted ΔG upon binding to 6 co-crystallized NAMPT structures. The compounds were then grouped into three binding classes based on 2D interactions with the NAMPT active and allosteric sites. The mode of action of 12 compounds was supported by the ligand alignments and center-of-mass distance measurements. The stability of NAMPT complexes with stylopine, hedychilactone A, and isobavachromene, as representatives of the three binding groups, was predicted by molecular dynamics simulations. The results of the virtual screening should inform the experimental development of anti-aging treatments and medicines for neurodegenerative diseases and brain cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Nahálková et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: